|
KR20200077911A
|
|
A pharmaceutical composition of sustained-release comprising zaltoprofen
|
|
KR20200068163A
|
|
Process for preparing cefmetazole sodium
|
|
KR20200032280A
|
|
Process for the proparation of contrast medium iomeprol
|
|
KR20200032281A
|
|
A New method for the production of citalopram and escitalopram using carbonates
|
|
KR20190119299A
|
|
Method for preparing triiodoisophthalamide x-ray contrast media ioversol
|
|
KR20170123748A
|
|
Novel intermediate compound and preparation process of iomeprol using thereof
|
|
KR20160112423A
|
|
Aripiprazole salt and process for preparing the same
|
|
KR20150128334A
|
|
Method of preparing purpurin 18 from live chlorella
|
|
KR20150047797A
|
|
Process for preparing flomoxef sodium
|
|
KR20100087931A
|
|
Precursive compound of rosuvastatin and manufacturing method for the precursive compound of rosuvastatin
|
|
KR20100050947A
|
|
Manufacturing method for iron oxide saccharated
|
|
KR20100034465A
|
|
Manufacturing method for crystallized pravastatin sodium salt purifying impure non-crystallized pravastatin sodium salt
|
|
KR20090062009A
|
|
Process of preparing of zaltoprofen'salt, and bioequivalent test and bioavailability analysis
|
|
KR20080037791A
|
|
Process for preparing (r)-2-hydroxy-2-(chlorophenyl)acetic methyl ester sulfate
|
|
KR20080035060A
|
|
Pegylated mycophenolic acid derivatives and process for preparing the same
|
|
KR20080035059A
|
|
Process for preparing s-(-)-amlodipine.hcl
|
|
KR20080035065A
|
|
Pegylated tacrolimus derivatives and process for preparing the same
|
|
KR20080035070A
|
|
Pegylated rapamycin derivatives and process for preparing the same
|
|
KR20080014265A
|
|
Process for preparing pegylated amphotericin b derivatives
|
|
KR20080014262A
|
|
Separation method of enantiomer of amlodipine racemate and process for preparing its hydrophilic drug
|
